Molecular formula: | C36H45NO7 |
Average mass: | 603.756 |
Monoisotopic mass: | 603.319603 |
ChemSpider ID: | 51216 |
0 of 1 defined stereocentres
Wikipedia
(±) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate
(±)-4-Hydroxy-a1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol 1-hydroxy-2-naphthalenecarboxylate (salt)
1-Hydroxy-2-naphthoesäure --2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1:1)
[German]
[ACD/IUPAC Name]1-Hydroxy-2-naphthoic acid - 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1:1)
[ACD/IUPAC Name]1-Hydroxynaphthalen-2-carbonsäure--2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzolol(1:1)
[German]
1-hydroxynaphthalene-2-carboxylic acid - 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol (1:1)
2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-α~1~-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1)
[ACD/Index Name]94749-08-3
[RN]Acide 1-hydroxy-2-naphtoïque - 2-(hydroxyméthyl)-4-(1-hydroxy-2-{[6-(4-phénylbutoxy)hexyl]amino}éthyl)phénol (1:1)
[French]
[ACD/IUPAC Name]acide 1-hydroxynaphtalène-2-carboxylique - 2-(hydroxyméthyl)-4-(1-hydroxy-2-{[6-(4-phénylbutoxy)hexyl]amino}éthyl)phénol (1:1)
[French]
GR 33343G
GR 33343X xinafoate
MFCD00897708
[MDL number]Salmeterol (xinafoate)
Salmeterol 1-hydroxy-2-naphthoate
Salmeterol Xinafoate
[JAN] [USAN] [USP](±) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol xinafoate, GR 33343X xinafoate, β₂
-Adrenoceptor Agonist, Salmeterol Xinafoate
1-hydroxy-2-naphthoic acid;4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-2-methylol-phenol
1-hydroxynaphthalene-2-carboxylic acid
1-HYDROXYNAPHTHALENE-2-CARBOXYLIC ACID; 4-(1-HYDROXY-2-{[6-(4-PHENYLBUTOXY)HEXYL]AMINO}ETHYL)-2-(HYDROXYMETHYL)PHENOL
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; 1-hydroxynaphthalene-2-carboxylic acid
2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;1-hydroxynaphthalene-2-carboxylic acid
2-carboxynaphthalen-1-olate and [2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]-[6-(4-phenylbutoxy)hexyl]azanium
4-(1-HYDROXY-2-((6-(4-PHENYLBUTOXY)HEXYL)AMINO)ETHYL)-2-(HYDROXYMETHYL)PHENOL 1-HYDROXY-2-NAPHTHOATE
4-(1-Hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol1-hydroxy-2-naphthoate
4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol 1-hydroxy-2-naphthalenecarboxylic acid
4-Hydroxy-α-({[6-(4-phenylbutoxy)hexyl]amino}methyl)-1,3-benzenedimethanol xinafoate
4-Hydroxy-α-({[6-(4-phenylbutoxy)hexyl]amino}methyl)-1,3-benzenedimethanol xinafoate; GR 33343X xinafoate
89365-50-4
[RN]94749-08-3 (xinafoate)
98%
Aeromax
Arial
[Wiki]Asmerole
Beglan
Betamican
Dilamax
GR 33343 G
GR 33343X xinafoate;Serevent Diskus
GR-33343 G
Inaspir
Salmetedur
Salmeterol xinafoate. Short expiry date due to chemical nature of component(s)
Salmeterol xinafonate
Salmeterol, 1-Hydroxy-2-naphthoate
SALMETEROLO
Salmeterolxinafoate
Serevent diskus
Ultrabeta